Prescriptions prove most expensive for cash-paying patients

In the last five years, insured Americans have been paying lower out-of-pocket costs for their prescriptions, but patients paying with cash are spending noticeably more, according to new analysis from the IQVIA Institute for Human Data Science.

Advertisement

The analysis reveals that the average cost for commercially insured prescriptions decreased from $10.83 to $8.90 from 2015-19. However, cash-paying patients without insurance are spending more, as their average monthly prescription cost increased to $50.78 from $36.77, and their average brand-name drug cost increased to $105.74 from $93.62.

The analysis also noted that 60 percent of all prescriptions with a final cost exceeding $500 are never picked up, compared to a 5 percent abandonment rate for prescriptions with no cost.

More articles on pharmacy:
Politicians should stay out of COVID-19 vaccine approval, health experts warn
Ban distracting music in drug ads, consumers advocates urge FDA
10 hospitals seeking pharmacy leaders

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.